Mobility paves Samsung’s silver path
The Korean giant’s early bet on mobile phones helped it hit the $10-bn mark in India, but in its 25th year it ...
A new experimental research proved to be effective against pneumonia in SARS-CoV-2 infected mice, as per the study carried by the researchers at the Washington University School of Medicine in St. Louis which was published in the News Medical Life Sciences journal.
The vaccine, made from a mild virus genetically modified to carry a key gene from the Covid-19 virus, is described in the journal Cell Host and Microbe.
“Unlike many of the other vaccines under development, this vaccine is made from a virus that is capable of spreading in a limited fashion inside the human body, which means it is likely to generate a strong immune response,” said co-senior author Michael S Diamond, MD, PhD, the Herbert S. Gasser Professor of Medicine and a professor of molecular microbiology, and of pathology and immunology.
Diamond mentioned that since the virus is capable of replicating, it can be grown to high levels in the lab, so it’s easy to scale up and should be more cost-effective than some of the other vaccine candidates.
He added: “So while what we have shown is just proof of concept, I think it’s very promising. Our vaccine candidate is now being tested in additional animal models with the goal of getting it into clinical trials as soon as possible.”
The researchers created the experimental vaccine by genetically modifying vesicular stomatitis virus (VSV), a virus of livestock that causes only a mild, short-lived illness in people.
They swapped out one gene from VSV for the gene for a spike from SARS-CoV-2, the virus that causes Covid-19. The hybrid virus is called VSV-SARS-CoV-2.
The researchers then induced VSV-SARS-CoV-2 in mice. A subgroup was boosted with a second dose of the experimental vaccine four weeks after the initial injections.
Three weeks after each injection, the researchers drew blood from the mice to test for antibodies capable of preventing SARS-CoV-2 from infecting cells.
They found high levels of such neutralising antibodies after one dose, and the levels increased 90-fold after a second dose.
In their last dose, researchers induced the SARS-CoV-2 virus into their noses. Four days post-vaccination, no infectious virus detectable in the lungs of mice that had been given either one or two doses of the vaccine. The vaccine completely eradicated pneumonia.
In contrast, mice that had received the placebo had high levels of virus in their lungs. In addition, the lungs of vaccinated mice showed fewer signs of inflammation and damage than those of mice that had received the placebo. The experimental vaccine is still in the early stages of development, News Medical Life Sciences published in its journal.
The Korean giant’s early bet on mobile phones helped it hit the $10-bn mark in India, but in its 25th year it ...
Antrix should adopt a different tactic than merely fighting over jurisdiction: Experts
Invest in relationships, enterprise, behaviour, effort and learning
From different types of osmoses to new membranes, researchers have come up with ways of drawing water
What filters should you apply when mining for under-the-radar small-cap stocks? Read on to find more
There’s no reason to bail out of your fund as long as it’s matching the category average
Amid choppiness, the benchmark indices slipped marginally; approach the week with caution
SBI Cards (₹1,032.7): Witnesses fresh breakoutBetween September and December last year, the stock of SBI Cards ...
What makes the new crop of young Indian cricketers such game-changing winners? Over and above their talent, ...
For their dead, Parsis practise a 3,000-year-old system where corpses are excarnated in the Tower of Silence, ...
The morning she gave Peter and Neha, and their baby daughter Minty, a tour of Ambassador Apartments, Mrs ...
It’s the 111th birth anniversary of jazz musician and guitar genius Jean ‘Django’ Reinhardt. This week’s quiz ...
Digital is becoming dominant media, but are companies and their ad agencies transforming fast enough to make a ...
Slow Network, promoted by journalist-lyricist Neelesh Misra, pushes rural products and experiences
How marketers can use the traditional exchange of festive wishes meaningfully
For Fortune, a brand celebrating its 20th anniversary, it was a rude shock to become the butt of social media ...
Three years after its inception, compliance with GST procedures remains a headache for exporters, job workers ...
Corporate social responsibility (CSR) initiatives of companies are altering the prospects for wooden toys of ...
Aequs Aerospace to create space for large-scale manufacture of toys at Koppal
And it has every reason to smile. Covid-19 has triggered a consumer shift towards branded products as ...
Please Email the Editor